ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
1-Year Outcomes of Lung Transplantation for Coronavirus Disease 2019-Associated End-Stage Lung Disease in the United States
Thursday, March 23, 2023
Submitted by
Source
Source Name: Oxford Academic
Source URL: https://doi.org/10.1093/cid/ciad072
Lung transplantation in COVID-19 patients with end-stage lung disease has proven to improve quality of life and be a viable treatment option. This study confirmed that by comparing a group of COVID-associated transplant patients with a group of patients needing transplants for other reasons. Although they had longer hospital stays, the COVID-related cases had a similar one-year survival rate to the other cohort.
Printer-friendly
